SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: nigel bates11/1/2006 8:50:09 AM
   of 1022
 
Posted on the Domantis website in October -

Domantis is pioneering the discovery and development of a new generation of proprietary antibody therapeutics that incorporate the biological benefits and commercial advantages of both large proteins and small molecules. Founded in 2000, we have a state-of-the-art R & D facility on the Cambridge Science Park in the UK and commercial offices in Waltham, Massachusetts in the USA.

Domantis is launching a major recruitment drive as we seek to expand our therapeutic pipeline. With this in mind we are looking to recruit bench scientists from a wide-range of disciplines related to dAb product generation. Applications from specialists in biological assay development, protein expression, molecular biology and antibody engineering are encouraged. Domantis offer a creative, dynamic and fast-paced working environment, competitive salaries, private medical cover, a contributory pension scheme and a generous share option package.

To be considered, please send a covering letter and detailed CV, including a full publication record and names of three references, either to jobs2006@domantis.com (for research group positions) or see the links below for specific additional vacancies.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext